These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38052269)

  • 1. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Bachert SE; Di J; Zhang S; Short HE; Piecoro DW; McDonald RJ; Myint ZW; Hensley PJ; Allison DB
    Hum Pathol; 2024 Jan; 143():42-49. PubMed ID: 38052269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic utility of trichorhinophalangeal syndrome type 1 immunohistochemistry for metastatic breast carcinoma in effusion cytology specimens.
    Chen CJ; Hang JF; Chen YA; Lin SJ; Chiu HM; Hsu CY; Lai CR; Yang CS
    Cancer Cytopathol; 2023 Apr; 131(4):226-233. PubMed ID: 36399408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Wu Y; Chen F; Pan L; Chao X; Li M; Luo R; Chen K; Zheng C; Du T; He J; Sun P
    Pathology; 2024 Jun; 56(4):516-527. PubMed ID: 38570266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
    Ai D; Yao J; Yang F; Huo L; Chen H; Lu W; Soto LMS; Jiang M; Raso MG; Wang S; Bell D; Liu J; Wang H; Tan D; Torres-Cabala C; Gan Q; Wu Y; Albarracin C; Hung MC; Meric-Bernstam F; Wistuba II; Prieto VG; Sahin AA; Ding Q
    Mod Pathol; 2021 Apr; 34(4):710-719. PubMed ID: 33011748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichorhinophalangeal Syndrome Type 1 Is a Highly Sensitive and Specific Marker for Diagnosing Triple-Negative Breast Carcinomas on Cytologic Samples.
    Lynn TJ; Shi J; Liu H; Monaco SE; Prichard JW; Lin F
    Arch Pathol Lab Med; 2024 Jan; 148(1):e1-e8. PubMed ID: 37406296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
    Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
    Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichorhinophalangeal syndrome type 1 (TRPS1) expression in male breast carcinoma.
    Law T; Piotrowski MJ; Ning J; Jiang X; Ding Q; Sahin AA
    Hum Pathol; 2023 Aug; 138():62-67. PubMed ID: 37331526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of TRPS1 Expression in Pleural Effusion Cytology Specimens With Metastatic Breast Carcinoma.
    Wang M; Stendahl K; Cai G; Adeniran A; Harigopal M; Gilani SM
    Am J Clin Pathol; 2022 Sep; 158(3):416-425. PubMed ID: 35760555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas.
    Bota EC; Koumoundourou D; Ravazoula P; Zolota V; Psachoulia C; Kardari M; Karampitsakos T; Tzouvelekis A; Tzelepi V; Sampsonas F
    Monaldi Arch Chest Dis; 2023 Aug; 94(2):. PubMed ID: 37667882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPS1 outperforms GATA3 in pleural effusions with metastatic breast carcinoma versus mesothelioma.
    Baban F; Koepplin JW; Ahmad M; Clarke-Brodber AL; Bois MC; Hartley CP; Sturgis CD
    Diagn Cytopathol; 2023 Aug; 51(8):488-492. PubMed ID: 37096814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
    Yoon EC; Wang G; Parkinson B; Huo L; Peng Y; Wang J; Salisbury T; Wu Y; Chen H; Albarracin CT; Resetkova E; Middleton LP; Krishnamurthy S; Gan Q; Sun H; Huang X; Shen T; Chen W; Parwani AV; Sahin AA; Li Z; Ding Q
    Hum Pathol; 2022 Jul; 125():97-107. PubMed ID: 35413381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder: A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma.
    Zhang GN; Susnik B; Paulsen EJ; Lyons LL; Delma KS; Jorda M; Epstein JI; Kryvenko ON
    Arch Pathol Lab Med; 2024 Oct; 148(10):1110-1118. PubMed ID: 38217332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E; Garg K; Stohr BA
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma.
    Bradt A; Jing X; Smola BS; Lew M
    Diagn Cytopathol; 2023 Nov; 51(11):665-673. PubMed ID: 37461248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation.
    Wang J; Peng Y; Sun H; Aung PP; Resetkova E; Yam C; Sahin AA; Huo L; Ding Q
    Arch Pathol Lab Med; 2024 Feb; 148(2):200-205. PubMed ID: 37074839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder.
    Plage H; Samtleben H; Hofbauer S; Kornienko K; Weinberger S; Bruch PG; Elezkurtaj S; Roßner F; Schallenberg S; Kluth M; Lennartz M; Blessin NC; Marx AH; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Minner S; Simon R; Sauter G; Klatte T; Schlomm T; Horst D; Zecha H
    Hum Pathol; 2022 Dec; 130():10-17. PubMed ID: 36152841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
    Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
    Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.